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Abstract
Hyponatremia is the most common electrolyte abnormality encountered both in the inpatient and outpatient clinical settings
in the United States. Rapid correction leads to a deranged cerebral osmotic gradient causing osmotic demyelination syndrome.
Coexisting azotemia is considered to be protective against osmotic demyelination syndrome owing to its counteractive
effect on osmolarity change that occurs with rapid hyponatremia correction. In this article, we report the case of a 37-yearold male who presented with altered mentation, acute azotemia, and severe electrolyte derangements, with serum blood
urea nitrogen 160 mg/dL, creatinine 8.4 mg/dL, sodium 107 mEq/L, potassium 6.1 mEq/L, bicarbonate 7 mEq/L, and anion
gap of 33. Given refractory hyperkalemia with electrocardiogram changes, emergent dialysis was performed. Despite our
efforts to avoid rapid correction, serum sodium was corrected to 124 mEq/L and blood urea nitrogen decreased to 87 mg/
dL at the end of the 5-hour dialysis session. Fortunately, hospital course and 4-week post-discharge clinic follow-ups were
uncomplicated with no neurological sequela confirmed by neurological examination and magnetic resonance imaging.
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Introduction
Osmotic demyelination syndrome (ODS), formerly called as
central pontine myelinolysis from rapid hyponatremia correction, was first described by Adams et al.1 Hyponatremia is
the most common electrolyte abnormality encountered in the
clinical practice with a reported prevalence of 9% to 31% for
a serum sodium (Na) <130 mEq/L and 0.03% to 0.49% for
serum Na <116 mEq/L.2,3 A study with National Health and
Nutrition Examination Survey data reported a prevalence of
1.72% among the United States general population.4 The
annual health care burden of hyponatremia is estimated to be
1.6 billion to 3.6 billion dollars.5 Human brains adaptation to
reduce the risk of cerebral edema from hypotonic hyponatremia itself makes it vulnerable to osmotic stress that develops
from rapid hyponatremia correction. The incidence of ODS is
reported to be very low at 0.5% to 2% in the general population and 10% among patients undergoing liver transplantation.6-9 Most occurred among subjects with a serum sodium
<120 mEq/L and a sodium correction of >10 to 12 mEq/L
in the initial 24 hours of presentation.8-12 Despite its low
incidence, given significant morbidity and mortality associated, it is still recommended to avoid the rapid correction
of hyponatremia. The recommended rate of hyponatremia

correction is 4 to 6 mEq/L in 24 hours. Among subjects with
severe symptomatic hyponatremia, this correction should be
achieved in the initial 4 to 6 hours with a maximum correction rate not exceeding 8 mEq/L within 24 hours.13,14 We
hereby report a case of azotemia with severe hyponatremia in
which sodium correction occurred rapidly devoid of any
neurological sequelae.

Case Report
A 37-year-old man with a past medical history of pancreatitis, type 2 diabetes mellitus on insulin, and ulcerative colitis
was brought to the emergency department with complaints
of nausea, vomiting, and diarrhea for a 1-week duration
1

Morehouse School of Medicine, Atlanta, GA, USA
Adventist Medical Center, Hanford, CA, USA
3
University of Kentucky, Lexington, KY, USA
2

Received February 5, 2020. Received March 4, 2020. Accepted March 7,
2020.
Corresponding Author:
Srinadh Annangi, University of Kentucky, 740 S LimeStone, Lexington,
KY 40506, USA.
Email: srinadhannangi@gmail.com

Creative Commons CC BY: This article is distributed under the terms of the Creative Commons Attribution 4.0 License
(https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission
provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

2
followed by anuria for 48 hours prior to this presentation.
Vital signs on presentation include a temperature of 36.3°C,
blood pressure of 103/60 mm Hg, heart rate of 79 beats per
minute, and respiratory rate of 16 breaths per minute, saturating at 100% on room air. On examination, the patient
appeared somnolent with dry mucous membranes and loss of
skin turgor. Limited neurologic examination was unremarkable. Comprehensive serum drug screen was negative.
Laboratory data are relevant for serum blood urea nitrogen
160 mg/dL, creatinine 8.4 mg/dL, Na 107 mEq/L, potassium
6.1 mEq/L, bicarbonate 7 mEq/L, anion gap of 33, glucose
169 mg/dL, and measured serum osmolality of 297 mOsm/L.
Electrocardiogram showed normal sinus rhythm with peak
T-waves. Urine studies revealed Na <10 mEq/L, creatinine
286 mg/dL, and osmolality of 311 mOsm/L, with hyaline
casts and fractional excretion of sodium of 0.6%. No prior
history of renal disease noted, and renal ultrasound was unremarkable. Given refractory and worsening hyperkalemia,
worsening uremia, and acidosis, emergent dialysis was
planned. However, the lowest sodium bath available for dialysis being 130 mEq, 0.45% normal saline was infused during
the dialysis session to prevent rapid sodium correction. He
received one session of hemodialysis and serum Na increased
to 124 mEq/L and blood urea nitrogen decreased to 87 mg/
dL during the 5-hour dialysis session. The patient’s mentation gradually improved, fully alert, awake, and oriented
without any immediate neurological deficits. Detailed neurological examination performed prior to discharge was also
unremarkable, including normal cranial nerve examination,
muscle strength, and deep tendon reflexes, sensory function,
gait, and coordination. Both T1- and T2-weighted imaging
sequences on magnetic resonance imaging (MRI) scan
performed 7 days after the rapid correction event was unremarkable. The patient’s neurological examination remained
unremarkable on his 4-week posthospital clinic follow-up.

Discussion
Osmotic demyelination syndrome or osmotic myelinolysis
was first described in alcoholics and in malnourished by
Adams et al in 1959; however, the etiological role of sodium
was not identified at that time.1 The etiological role of sodium
correction rate in causing myelinolysis was confirmed later
in animal models.15 Serum Na is the primary determinant of
serum tonicity. As hyponatremia develops, brain cells adapt
by the efflux of organic and inorganic osmolytes to avoid
relative hypotonicity. Efflux of inorganic osmolytes like
potassium and chloride occurs within minutes to hours,
which is followed by a delayed efflux of organic osmolytes
like amino acids over the next few days.16,17 During the
hyponatremia correction, brain cells should adapt to relative
hypertonicity caused by increasing extracellular sodium concentrations. This adaption occurs by the influx of osmolytes
back into brain cells. As organic solutes take longer time to
reaccumulate, in the event of a rapid correction, delayed
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reaccumulation of organic solutes leads to a relatively hypertonic serum compared with brain cells eventually causing an
efflux of water leading to ODS.18
On the other hand, rapid correction of azotemia in dialysis leads to cerebral edema owing to slower diffusion of
urea across the blood-brain barrier.19 In animal studies, the
presence of concurrent azotemia decreased the incidence
and severity of myelinolysis with rapid hyponatremia
correction.16 Acute azotemia being hypertonic state triggers
the intracellular accumulation of organic osmolytes as an
adaptive mechanism to prevent water influx into brain
cells.20 This also leads to the synthesis of transporters for
organic osmolytes facilitating rapid redistribution with azotemia correction.21 The increased intracellular concentration of cerebrospinal fluid urea and other organic osmolytes
seen with azotemia state partially counteracts the extracellular hyperosmolarity that develops with rapid hyponatremia correction.
The above-mentioned counteracting mechanism of azotemia and hyponatremia on cerebral osmolarity, when coexist,
was postulated to have a possible protective effect in preventing ODS from rapid sodium correction.16,21,22 One such observation was from retrospective analysis done by Dhrolia
et al supporting the protective effect of azotemia.23 In their
retrospective analysis, none of their 52 subjects with azotemia and hyponatremia developed ODS despite a mean
24-hour sodium correction by 15.4 (±3.4). However, in
this analysis, neurological examination was reported immediately after dialysis and only 2 out of 52 subjects had MRI
performed. MRI is the recommended imaging to diagnose
ODS. Characteristic findings include symmetric signal
hyperintensity in the central pons on T2-weighted and fluid
attenuation inversion recovery sequences with corresponding decreased T1-weighted signal.24,25 Clinical manifestations of myelinolysis are usually not apparent immediately
and are often delayed by up to 5 to 6 days after rapid sodium
correction. Absence of MRI findings and delayed neurologic
examination in that study, it would be a dangerous assumption to conclude that uremia had prevented ODS among all
their study subjects.26-28 Fortunately, our case did not have
any neurologic sequelae confirmed by delayed neurological
testing and MRI imaging. Nevertheless, not all patients with
azotemia and hyponatremia can be protective against ODS
and clinical models to pinpoint at-risk populations for ODS
are not yet developed. ODS among uremic subjects with
rapid sodium correction has been reported and confirmed by
delayed neurological examination and MRI.26,29-31 Until further evidence, it will be premature to conclude that uremia
prevents ODS, as this might lead a false sense of assurance
among the physicians and not to follow any preventive measures to avoid rapid sodium correction. Given the detrimental effects of ODS and lack of sustained evidence on the
protective effect of azotemia, physicians should follow all
possible precautions to avoid rapid sodium correction. Few
such measures include reduction of dialysate sodium,
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infusion of hypotonic saline with dialysis, increasing dialysis
duration, or perform intermittent short duration sessions if
clinically feasible.
Osmotic demyelination syndrome is a rare preventable
complication of rapid hyponatremia correction and is associated with significant morbidity and mortality. Though azotemia was proposed to be protective, not all previously reported
cases with azotemia were fortunate enough to be exempt from
developing ODS. Given the detrimental effects of this preventable condition, until further evidence, physicians should
still follow all the necessary steps to avoid rapid hyponatremia correction even among cases with concurrent azotemia.
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